TENAX THERAPEUTICS, INC. Balance Sheet
TENX|7 years of annual SEC 10-K data (FY2012-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
TENAX THERAPEUTICS, INC. had $104M in total assets and $92M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | $94.9M | $7.9M | $783.5K | $1.9M | $1.9M | $0 |
| Accounts Receivable | - | - | $72.6K | $36.4K | $36.4K | $445.2K | $13.4K |
| Inventory | - | - | - | - | - | $99.2K | $83.4K |
| Current Assets | $104.2M | $96.7M | $13.6M | $59.0M | $59.0M | $1.8M | $2.6M |
| PP&E (Net) | - | - | $19.1K | $124.4K | $124.4K | $205.4K | $293.6K |
| Goodwill | - | - | - | $11.3M | $11.3M | - | - |
| Total Assets | $104.2M | $96.7M | $23.3M | $93.4M | $93.4M | $3.2M | $4.1M |
| Current Liabilities | $7.2M | $4.7M | $6.2M | $2.6M | $2.6M | $1.9M | $3.1M |
| Shareholders' Equity | $92.0M | $8.1M | $60.4M | -$1.8M | -$1.8M | -$346.0K | -$3.7M |